Adaptation of the Tool to Estimate Patient Costs Questionnaire into Indonesian Context for Tuberculosis-affected Households
WHO. Global tuberculosis report. Geneva: World Health Organization; 2016.
Tanimura T, Jaramillo E, Weil D, Raviglione M, Lonnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014;43(6):1763-75.
K.F. O, Salomon JA, Barnighausen T, Atun R. Stopping tuberculosis: a biosocial model for sustainable development. Lancet. 2015;386:2354-62.
Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, et al. Defining Catastrophic Costs and Comparing Their Importance for Adverse Tuberculosis Outcome with Multi-Drug Resistance: A Prospective Cohort Study, Peru. Plos Medicine. 2014;11(7).
Organization WH. Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization, 2013 29 November 2013. Report No.: EB134/12.
Organization WH. Protocol for survey to determine direct and indirect costs due to TB and to estimate proportion of TB-affected households experiencing catastrophic total costs due to TB. Geneva: World Health Organization; 2015 November 2015.
Mauch V, Woods N, Kirubi B, Kipruto H, Sitienei J, Klinkenberg E. Assessing access barriers to tuberculosis care with the tool to Estimate Patients' Costs: pilot results from two districts in Kenya. Bmc Public Health. 2011;11.
TB-CTA. The tool to estimate patient's costs. The Hague: KNCV; 2009 2009.
Epstein J, Santo RM, Guillemin F. A review of guidelines for cross-cultural adaptation of questionnaires could not bring out a consensus. J Clin Epidemiol. 2015;68(4):435-41.
Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res2010.
Tiemersma E, Hafidz F. Costs faced by (multidrug resistant) tuberculosis patients during diagnosis and treatment: report from a pilot study in Indonesia. The Hague: KNCV Tuberculosis Foundation, 2014 February 2014. Report No.
van den Hof S, Collins D, Hafidz F, Beyene D, Tursynbayeva A, Tiemersma E. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan. BMC Infect Dis. 2016;16:470.
Bruyere O, Demoulin M, Beaudart C, Hill JC, Maquet D, Genevay S, et al. Validity and Reliability of the French Version of the STarT Back Screening Tool for Patients With Low Back Pain. Spine. 2014;39(2):E123-E8.
Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186-91.
- There are currently no refbacks.